Drugs anti-inflammatories

R. Haynes (Oxford, United Kingdom)

Source: Virtual Congress 2020 – Management

Session: Management
Session type: COVID-19
Number: 3639

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
R. Haynes (Oxford, United Kingdom). Drugs anti-inflammatories. Virtual Congress 2020 – Management

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.

Related content which might interest you:

Management of COVID-19: Drugs anti-inflammatories Source: ERS Course 2021 - COVID-19: State of the art Year: 2021
Drugs anti-virals Source: Virtual Congress 2020 – Management Year: 2020
Anti-tuberculosis drugs Source: International Congress 2017 – State of the art session: "Respiratory infections" Year: 2017
Novel anti-inflammatory agents Source: Annual Congress 2009 - Emerging trends in the therapy of COPD Year: 2009
Macrolides as anti-inflammatory agents in CAP Source: Eur Respir Monogr 2014; 63: 243-255 Year: 2014
Management of COVID-19: Drugs anti-virals Source: ERS Course 2021 - COVID-19: State of the art Year: 2021
New twists in the pharmacology of NSAID drugs Source: Annual Congress 2007 - Recent advances in our understanding of the mechanisms of asthma treatment Year: 2007
Targeting neuropetides: from antiemetics to bronchodilators? Source: Annual Congress 2012 - ERS Romain Pauwels Research Award Ceremony (supported by GlaxoSmithKline) followed by the Hot Topic "The nerves are back!" Year: 2012
Nonsteroidal anti-inflammatory drugs in community-acquired pneumonia Source: Eur Respir J 2015; 46: 875-876 Year: 2015
Nonsteroidal anti-inflammatory drugs in community-acquired pneumonia Source: Eur Respir J 2015; 46: 876-877 Year: 2015
Prospects for new compounds tiosemikarbazonami class to create drugs with antituberculosis activity Source: International Congress 2014 – Tuberculosis: diagnosis Year: 2014
New and repurposed drugs Source: Eur Respir Monogr 2018; 82: 179-204 Year: 2018
Evaluation of antituberculous drugs administration Source: Eur Respir J 2002; 20: Suppl. 38, 547s Year: 2002
Macrolides, mucoactive drugs and adherence for the management of bronchiectasis Source: Eur Respir J, 51 (1) 1702033; 10.1183/13993003.02033-2017 Year: 2018
Macrolides, mucoactive drugs and adherence for the management of bronchiectasis Source: Eur Respir J, 51 (1) 1701987; 10.1183/13993003.01987-2017 Year: 2018
Manifestations of hypersensitivity to anti-tuberculosis drugs Source: International Congress 2018 – Challenges in tuberculosis care Year: 2018
Opioids Source: ERS Online Course 2016 Year: 2016
Drug resistant pattern of antitubercular drugs in India Source: Annual Congress 2008 - Epidemiology and clinical management of multidrug-resistant and extensively drug-resistant tuberculosis Year: 2008